Please assess the completion status of the following clinical trial:

Trial Title: Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with suspected CAD referred for CTA and found to have moderate CAD stenoses and 20 normal volunteers with less than 5% probability of CAD.~2. Age ≥ 18 years~Exclusion Criteria:~1. Inability to undergo stress protocol due to co-morbidities~2. Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 18F-FDG PET imaging (Type: EXPERIMENTAL): Positron Emission Tomography nuclear stress scan following either pharmacologic or treadmill stress test with radiopharmaceutical injection at peak stress or within 1 hour following peak stress.

Based on this trial design, predict the completion outcome and termination type (if applicable).